This presentation will focus on how PETs relate to data protection law and identifying potential areas for PETs implementation and how to do so effectively. This will follow into a focus on the future direction of PETs maturity and standardisation efforts.
David will discuss the importance of a customer-centric approach to building PET-based applications. He will provide examples of how too much emphasis on the merits of technologies can often lead to misalignment between service providers and potential adopters and how a customer-centric approach can bridge this gap. David will share lessons learned over the past two years of talking to customers to understand their pain, concerns, fears, and expectations when it comes to dealing with data and how that ended up being the best compass for Algemetric's decisions. He will also discuss how customers have a unique insight into their business problems and how listening to them in every step of building a solution can be beneficial for developing successful PET-based solutions
David William Silva is a Ph.D computer scientist. He is responsible for translating business strategies and objectives into efficient, user-friendly, secure, and privacy-preserving data-centric solutions to enable organizations to extract maximum value from data correctly. David started his career as a Software Engineer focused on web services and agile software development. This experience led him to be involved with several projects, from startups to government and large corporations in many different fields. After 17 years of conducting R&D in Brazil, David moved to the US to engage in scientific research applied to a global industry of security and privacy, which has been his focus for the past nine years.
Arvind Jagannath works in Product Management at VMware. With over 25 years of experience in the industry working on networking, storage, embedded, and kernel development, he currently leads infrastructure and core platform enablement for vSphere, working across the VMware ecosystem of server, IO, and storage partners. Arvind most recently drove platform product management at Cohesity and NetApp. Arvind holds an MBA from the University of Chicago, Booth school of Business and a Bachelors in Computer Science and Engineering.
Samir Rajadnya is currently a Principal Architect in Microsoft's Azure Hardware Architecture team, which is responsible for long-range technology pathfinding for future Azure Cloud systems. Within AHA, Samir is part of a team responsible for future memory systems. This team investigates future architecture directions for Azure and serves as the primary architecture contact point in technical relationships with compute, memory, and device partners.
Prior to joining Microsoft, Samir spent many years innovating in memory, storage, and networking. Samir was key architect to productize 3DXP technology at Micron, architect, and designer at disruptive storage startup DSSD. Samir was SOC architect and designer at Juniper Networks, Netronome and Intel.
Samir has served as part of multiple industry standards bodies throughout his career, including CXL and CCIX.
Samir received his Master’s in Electrical Engineering from Indian Institute of Technology Bombay.
Specialties: Computer architecture, memory technologies, storage technologies, SOC architecture
Sandra Shpilberg (she/her, Hispanic) is the co-founder and CEO of Adnexi, a leading Key Opinion Leader discovery & mapping solution for biopharma companies developing the next generation of life-changing and life-saving treatments. Adnexi's mission is to transform massive data into actionable strategies to improve KOL relationships and diversity in clinical trials. Prior to this, Shpilberg started and built Seeker Health, a digital patient-finding platform to accelerate the development of treatments for patients who really need them. Seeker Health was acquired by EVERSANA. Prior to these entrepreneurial pursuits, Shpilberg held executive roles at biopharmaceutical companies. She served as Vice President of Commercial Development and Strategic Marketing for Nora Therapeutics, and as Executive Director at BioMarin Pharmaceutical where she led the commercial launches of NAGLAZYME and KUVAN, and advanced the product development of PALINZIQ from Phase 2 to Phase 3. She's the author of the award-winning book New Startup Mindset.
